Paul Aykroyd

Defaqto Ltd. operates as a financial services technology firm that develops a fintech platform for advisers and also provides independent ratings of financial products and funds. It offers ratings, software solutions, consultancy and data services, and publications and events. The company was founded by Alastair Harold Whitehead in 1994 and is headquartered in Haddenham, the United Kingdom.

Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany.

TouchType Ltd. develops application that replaces the on-screen keyboard of the mobile phone. It engages in the development of mobile application solutions. The firm develops SwiftKey Keyboard, which is an application that replaces the on-screen keyboard of the mobile phone. It also offers SwiftKey Cloud, which is packed with features that make the SwiftKey Keyboard learns from typing habits. The company was founded by Jonathan Reynolds and Benjamin W. Medlock in 2008 and is headquartered in London, the United Kingdom.

Cytora Ltd. provides a cloud based risk analysis platform that allows customers to view risk data relevant to their organization. Its platform enables clients to filter, identify, and analyze risk events discovered in real time. The company was founded by Richard Hartley, Joshua Wallace, Andrzej Czapiewski and Aeneas Wiene in 2013 and is headquartered in Clerkenwell, the United Kingdom.

Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom.

Sanome Ltd is a British biotechnology company founded in 2021. The company is based in Cambridge, UK and has subsidiaries in United Kingdom. Sanome engages in research and development of biotechnology.

Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation.